ArticlePharmaceutics2022

Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion Formulation.

Rajiv Bajracharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.